Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
Influence of sedentary behaviour and physical activity on clinical response to a therapeutic dietary intervention in Crohn’s disease
EF 2023-24
Résumé
Inflammatory bowel disease (IBD) is a life-long gastrointestinal disease that has no cure. There are two primary manifestations of IBD, Crohn’s disease and ulcerative colitis. The symptoms associated with IBD are severe and IBD patients have a collectively lower quality of life when compared to healthy individuals. The purpose of this study is to assess how physical activity (PA) and sedentary behavior affect patient response to a personalized therapeutic dietary intervention in Crohn’s disease. We believe that higher levels of habitual, or routine, physical activity will reduce the time it takes to achieve remission (reduction in symptoms and inflammation) in adult patients with active Crohn’s disease while undergoing a therapeutic dietary intervention. In this 13-week randomized controlled trial, patients with Crohn’s disease will be randomly assigned to either the intervention group or the normal, conventional management group. Habitual PA and sedentary behaviour will be assessed using wearable technology, specifically, the Actigraph® GT3X+ accelerometer and ActivPAL® inclinometer. Our primary objective will be to investigate the influence of habitual PA and sedentarism on patient response to a therapeutic diet. Patient response will be measured using a stool sample to measure a biomarker of inflammation in the gut and a self-report questionnaire of symptom severity. We will also measure patient quality of life using a self-report questionnaire. Our work will inform clinicians and patients on the potential for PA to improve response to a therapeutic diet for Crohn’s disease and reduce time to remission from active Crohn’s disease. It may also encourage the use of wearable technology in the management of IBD.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506198
Name
Toews Briana
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Influence of sedentary behaviour and physical activity on clinical response to a therapeutic dietary intervention in Crohn’s disease
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Accelerometry; Crohn'S Disease; Diet; Gastroenterology; Inflammatory Bowel Disease; Personalized Nutrition; Physical Activity; Quality Of Life; Sedentary Behavior; Wearable Technology
Abstract
Inflammatory bowel disease (IBD) is a life-long gastrointestinal disease that has no cure. There are two primary manifestations of IBD, Crohn’s disease and ulcerative colitis. The symptoms associated with IBD are severe and IBD patients have a collectively lower quality of life when compared to healthy individuals. The purpose of this study is to assess how physical activity (PA) and sedentary behavior affect patient response to a personalized therapeutic dietary intervention in Crohn’s disease. We believe that higher levels of habitual, or routine, physical activity will reduce the time it takes to achieve remission (reduction in symptoms and inflammation) in adult patients with active Crohn’s disease while undergoing a therapeutic dietary intervention. In this 13-week randomized controlled trial, patients with Crohn’s disease will be randomly assigned to either the intervention group or the normal, conventional management group. Habitual PA and sedentary behaviour will be assessed using wearable technology, specifically, the Actigraph® GT3X+ accelerometer and ActivPAL® inclinometer. Our primary objective will be to investigate the influence of habitual PA and sedentarism on patient response to a therapeutic diet. Patient response will be measured using a stool sample to measure a biomarker of inflammation in the gut and a self-report questionnaire of symptom severity. We will also measure patient quality of life using a self-report questionnaire. Our work will inform clinicians and patients on the potential for PA to improve response to a therapeutic diet for Crohn’s disease and reduce time to remission from active Crohn’s disease. It may also encourage the use of wearable technology in the management of IBD.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Toews, Briana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~